The use of recombinant hepatitis B vaccines has led to the effective prevention of hepatitis B infection and its chronic sequelae in immunocompetent individuals. Whilst rare, a variety of serious adverse effects have been reported following vaccination including cutaneous vasculitis in eight previous cases. We describe a case of Henoch-Schönlein purpura developing after hepatitis B vaccination.
No takes yet. Share an insight, caveat, or question.
Chave et al. (2003) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: